Insights into NAFLD & Cognitive Function 2022
I n a recent review published in Cell & Bioscience , many of the common pathologies characteristic of non-alcoholic fatty liver disease (NAFLD) are discussed, as well as how they overlap and contribute to the onset and progression of dementia. To help understand the scope of this problem, it’s worth noting that although the precise prevalence of NAFLD is not clear, it is almost certainly widespread. A cross-sectional study using data from the 11-14 NHANES (National Health and Nutrition Examination Survey) pins the prevalence at 21.9% among US adults over 20, including over 12 million with F2 fibrosis and 5 million with at least F3 fibrosis. It’s also important to note that this estimate used a very strict definition of NAFLD, requiring the presence of both metabolic syndrome and elevated ALT levels; definitions that did not include these requirements have estimated a prevalence of NAFLD nearly twice as high, affecting as many as 100 million adults...